{"id":37998,"date":"2026-04-27T13:49:51","date_gmt":"2026-04-27T11:49:51","guid":{"rendered":"https:\/\/kymos.com\/?p=37998"},"modified":"2026-04-27T13:55:39","modified_gmt":"2026-04-27T11:55:39","slug":"solucions-integrals-per-a-estudis-preclinics-de-salut-animal-de-bioequivalencia-i-clinics","status":"publish","type":"post","link":"https:\/\/kymos.com\/ca\/news\/solucions-integrals-per-a-estudis-preclinics-de-salut-animal-de-bioequivalencia-i-clinics\/","title":{"rendered":"Bioan\u00e0lisi de cannabinoides: un m\u00e8tode LC-MS\/MS multian\u00e0lit validat en plasma hum\u00e0"},"content":{"rendered":"<div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 fusion-flex-container nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-flex-wrap:wrap;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start fusion-flex-content-wrap\" style=\"max-width:calc( 1170px + 20px );margin-left: calc(-20px \/ 2 );margin-right: calc(-20px \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_1 1_1 fusion-flex-column\" style=\"--awb-bg-size:cover;--awb-width-large:100%;--awb-margin-top-large:0px;--awb-spacing-right-large:10px;--awb-margin-bottom-large:0px;--awb-spacing-left-large:10px;--awb-width-medium:100%;--awb-spacing-right-medium:10px;--awb-spacing-left-medium:10px;--awb-width-small:100%;--awb-spacing-right-small:10px;--awb-spacing-left-small:10px;\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-text fusion-text-1\"><p><span style=\"font-size: 14pt;\">L&#8217;<strong>inter\u00e8s creixent en les ter\u00e0pies basades en cannabinoides<\/strong> ha comportat una <strong>demanda creixent de m\u00e8todes bioanal\u00edtics robustos i fiables capa\u00e7os de donar suport als programes de desenvolupament de f\u00e0rmacs<\/strong>. M\u00e9s enll\u00e0 de la quantificaci\u00f3 dels compostos parentals com el cannabidiol (CBD) i el tetrahidrocannabinol (THC), hi ha una <strong>necessitat clara de monitorar amb precisi\u00f3 els seus principals metab\u00f2lits per caracteritzar millor la farmacocin\u00e8tica, la biodisponibilitat i l&#8217;exposici\u00f3 general al f\u00e0rmac<\/strong>. <\/span><\/p>\n<p><span style=\"font-size: 14pt;\">No obstant aix\u00f2, la determinaci\u00f3 simult\u00e0nia de m\u00faltiples cannabinoides i els seus metab\u00f2lits en matrius biol\u00f2giques presenta reptes anal\u00edtics significatius. En aquest context, Kymos <a href=\"https:\/\/kymos.com\/ca\/news\/un-metode-lc-ms-ms-per-a-quatre-cannabinoides\/\" data-wpel-link=\"internal\">ha ampliat encara m\u00e9s la seva experi\u00e8ncia<\/a> en la bioan\u00e0lisi de cannabinoides mitjan\u00e7ant el <strong>desenvolupament i la validaci\u00f3 d&#8217;un m\u00e8tode LC-MS\/MS sensible i robust per a la quantificaci\u00f3 simult\u00e0nia de sis an\u00e0lits clau, inclosos el CBD, el THC i els seus principals metab\u00f2lits en plasma hum\u00e0.<\/strong> <\/span><\/p>\n<h2><strong>Reptes anal\u00edtics en la bioan\u00e0lisi de cannabinoides<\/strong><\/h2>\n<p><span style=\"font-size: 14pt;\">La bioan\u00e0lisi de cannabinoides \u00e9s inherentment complexa a causa de diversos factors. <strong>Aquests compostos solen estar presents en concentracions baixes, cosa que requereix t\u00e8cniques anal\u00edtiques altament sensibles<\/strong>. A m\u00e9s, la similitud estructural entre els compostos parentals i els seus metab\u00f2lits exigeix una <strong>alta selectivitat per garantir una quantificaci\u00f3 precisa<\/strong>. <\/span><\/p>\n<p><span style=\"font-size: 14pt;\">Un altre repte clau rau en la <strong>necessitat de cobrir un ampli rang din\u00e0mic de concentracions en un sol m\u00e8tode<\/strong>, especialment quan s&#8217;inclouen tant els compostos parentals com els metab\u00f2lits. A m\u00e9s, les matrius biol\u00f2giques com el plasma hum\u00e0 introdueixen possibles interfer\u00e8ncies, fet que fa que una <strong>preparaci\u00f3 eficient de les mostres sigui essencial<\/strong>. <\/span><\/p>\n<p><span style=\"font-size: 14pt;\">Finalment, les expectatives reguladores han evolucionat, amb directrius com la <strong>ICH M10, que estableix requisits clars per a la validaci\u00f3 de m\u00e8todes bioanal\u00edtics<\/strong>, refor\u00e7ant la necessitat de metodologies robustes, reprodu\u00efbles i conformes.<\/span><\/p>\n<h2><strong>Descripci\u00f3 general del m\u00e8tode<\/strong><\/h2>\n<h3><strong>An\u00e0lits objectiu i rangs de calibratge<\/strong><\/h3>\n<p><span style=\"font-size: 14pt;\">El m\u00e8tode desenvolupat permet la quantificaci\u00f3 simult\u00e0nia de sis an\u00e0lits, inclosos tant els compostos parentals com els seus metab\u00f2lits primaris:<\/span><\/p>\n<ul>\n<li><span style=\"font-size: 14pt;\"><strong>CBD<\/strong>: 0,5\u2013100 ng\/mL<\/span><\/li>\n<li><span style=\"font-size: 14pt;\"><strong>7-OH-CBD<\/strong>: 0,5\u201350 ng\/mL<\/span><\/li>\n<li><span style=\"font-size: 14pt;\"><strong>7-COOH-CBD<\/strong>: 0,5\u2013500 ng\/mL<\/span><\/li>\n<li><span style=\"font-size: 14pt;\"><strong>THC<\/strong>: 0,5\u2013100 ng\/mL<\/span><\/li>\n<li><span style=\"font-size: 14pt;\"><strong>11-OH-THC<\/strong>: 0,5\u201350 ng\/mL<\/span><\/li>\n<li><span style=\"font-size: 14pt;\"><strong>11-COOH-THC<\/strong>: 0,5\u2013500 ng\/mL<\/span><\/li>\n<\/ul>\n<p><span style=\"font-size: 14pt;\">Aquest <strong>ampli rang de calibratge<\/strong> permet que el m\u00e8tode cobreixi les concentracions observades habitualment en estudis cl\u00ednics, donant suport a avaluacions farmacocin\u00e8tiques exhaustives.<\/span><\/p>\n<h3><strong>Estrat\u00e8gia de preparaci\u00f3 de mostres<\/strong><\/h3>\n<p><span style=\"font-size: 14pt;\">La preparaci\u00f3 de la mostra es basa en <strong>200 \u00b5L de plasma hum\u00e0<\/strong> utilitzant <strong>K\u2012EDTA com a anticoagulant<\/strong>. S&#8217;aplica un pas de precipitaci\u00f3 de prote\u00efnes amb acetonitril, seguit d&#8217;una <strong>filtraci\u00f3 mitjan\u00e7ant plaques de 96 pous Phree\u2122 Phospholipid Removal<\/strong>. <\/span><\/p>\n<p><span style=\"font-size: 14pt;\">Aquest enfocament garanteix una eliminaci\u00f3 eficient dels fosfol\u00edpids i altres components de la matriu, millorant la <strong>robustesa del m\u00e8tode i minimitzant els efectes de la matriu, alhora que \u00e9s adequat per a l&#8217;an\u00e0lisi d&#8217;alt rendiment<\/strong>.<\/span><\/p>\n<h3><strong>An\u00e0lisi instrumental<\/strong><\/h3>\n<p><span style=\"font-size: 14pt;\"><strong>La quantificaci\u00f3 de tots els an\u00e0lits es realitza mitjan\u00e7ant LC-MS\/MS, cosa que permet una alta sensibilitat i selectivitat.<\/strong>  El m\u00e8tode est\u00e0 dissenyat per garantir una detecci\u00f3 fiable en tots els compostos en una sola s\u00e8rie anal\u00edtica, donant suport a una an\u00e0lisi multian\u00e0lit eficient.<\/span><\/p>\n<p><span style=\"font-size: 14pt;\">El sistema es <strong>basa en un espectr\u00f2metre de masses Triple Quad 6500+ (Sciex), equipat amb una font d&#8217;ions TurboIonSpray,<\/strong> que proporciona la sensibilitat i la robustesa necess\u00e0ries per a la quantificaci\u00f3 de cannabinoides i els seus metab\u00f2lits en un ampli rang de concentracions.<\/span><\/p>\n<h2><strong>Validaci\u00f3 de m\u00e8todes segons ICH M10<\/strong><\/h2>\n<p><span style=\"font-size: 14pt;\"><strong>El m\u00e8tode va ser completament validat segons les Bones Pr\u00e0ctiques de Laboratori (BPL) d&#8217;acord amb la directriu ICH M10<\/strong>. La validaci\u00f3 va confirmar que el <strong>m\u00e8tode \u00e9s selectiu, lineal i compleix els requisits bioanal\u00edtics de precisi\u00f3, exactitud i efectes de matriu.<\/strong> Tamb\u00e9 es van demostrar l&#8217;estabilitat, l&#8217;arrossegament i la idone\u00eftat per a alt rendiment, cosa que dona suport a una an\u00e0lisi fiable en estudis regulats. <strong>El m\u00e8tode assoleix un l\u00edmit inferior de quantificaci\u00f3 (LLOQ) de 0,5 ng\/mL per a tots els analits<\/strong>. <\/span><\/p>\n<h2><strong>Punts forts clau del m\u00e8tode<\/strong><\/h2>\n<ul>\n<li><span style=\"font-size: 14pt;\"><strong>Quantificaci\u00f3 simult\u00e0nia de sis cannabinoides<\/strong> i metab\u00f2lits en un sol m\u00e8tode<\/span><\/li>\n<li><span style=\"font-size: 14pt;\"><strong>Ampli rang de calibratge<\/strong> que cobreix tant els compostos parentals com els metab\u00f2lits<\/span><\/li>\n<li><span style=\"font-size: 14pt;\">Alta sensibilitat, amb un <strong>LLOQ de 0,5 ng\/mL<\/strong><\/span><\/li>\n<li><span style=\"font-size: 14pt;\">Preparaci\u00f3 de mostres eficient i <strong>robusta<\/strong><\/span><\/li>\n<li><strong><span style=\"font-size: 14pt;\">Totalment validat sota BPL en compliment de la ICH M10<\/span><\/strong><\/li>\n<\/ul>\n<h2><strong>Aplicacions en el desenvolupament de f\u00e0rmacs<\/strong><\/h2>\n<p><span style=\"font-size: 14pt;\">Aquest m\u00e8tode \u00e9s molt adequat per <strong>donar suport a una \u00e0mplia gamma d&#8217;estudis que involucren compostos basats en cannabinoides<\/strong>, incloent-hi:<\/span><\/p>\n<ul>\n<li><span style=\"font-size: 14pt;\">Estudis farmacocin\u00e8tics<\/span><\/li>\n<li><span style=\"font-size: 14pt;\">Assajos cl\u00ednics (fases I\u2013IV)<\/span><\/li>\n<li><span style=\"font-size: 14pt;\">Estudis de biodisponibilitat i bioequival\u00e8ncia<\/span><\/li>\n<li><span style=\"font-size: 14pt;\">Estudis d&#8217;interacci\u00f3 farmacol\u00f2gica<\/span><\/li>\n<\/ul>\n<p><span style=\"font-size: 14pt;\">La seva capacitat per quantificar simult\u00e0niament m\u00faltiples an\u00e0lits el fa especialment <strong>valu\u00f3s per a l&#8217;avaluaci\u00f3 exhaustiva de l&#8217;exposici\u00f3 i el perfil de metab\u00f2lits en entorns cl\u00ednics.<\/strong><\/span><\/p>\n<h2><strong>Conclusi\u00f3<\/strong><\/h2>\n<p><span style=\"font-size: 14pt;\">Una bioan\u00e0lisi de cannabinoides fiable requereix un equilibri prec\u00eds entre una alta sensibilitat i una selectivitat rigorosa. En abordar aquests reptes directament, <strong>aquest m\u00e8tode LC-MS\/MS validat per a sis an\u00e0lits ofereix una soluci\u00f3 que compleix les BPL per al perfil simultani de metab\u00f2lits en plasma hum\u00e0.<\/strong> <\/span><\/p>\n<p><span style=\"font-size: 14pt;\">La capacitat de <strong>rastrejar tant els compostos parentals com els seus metab\u00f2lits primaris en una sola s\u00e8rie agilitza els fluxos de treball cl\u00ednics i garanteix la integritat de les dades<\/strong> necess\u00e0ria per al desenvolupament de f\u00e0rmacs moderns. Aquesta capacitat ampliada proporciona el suport bioanal\u00edtic robust necessari en la farmacocin\u00e8tica de cannabinoides i la presentaci\u00f3 reglament\u00e0ria. <\/span><\/p>\n<p><span style=\"font-size: 14pt;\">Per a m\u00e9s informaci\u00f3 sobre com aquests m\u00e8todes validats poden donar suport als vostres programes cl\u00ednics o per parlar d&#8217;una estrat\u00e8gia bioanal\u00edtica personalitzada, poseu-vos en contacte amb el nostre equip t\u00e8cnic a <a href=\"https:\/\/kymos.com\/ca\/contacte\/\" data-wpel-link=\"internal\">https:\/\/kymos.com\/contact<\/a><\/span><\/p>\n<\/div><\/div><\/div><\/div><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":8,"featured_media":38005,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[95,69],"tags":[],"class_list":["post-37998","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-bioanalisi","category-general"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Bioan\u00e0lisi de cannabinoides: m\u00e8tode LC-MS\/MS validat per a 6 an\u00e0lits<\/title>\n<meta name=\"description\" content=\"Sis cannabinoides, un sol m\u00e8tode: an\u00e0lisi LC-MS\/MS validada amb una gran sensibilitat i selectivitat a Kymos Group.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/kymos.com\/ca\/news\/solucions-integrals-per-a-estudis-preclinics-de-salut-animal-de-bioequivalencia-i-clinics\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bioan\u00e0lisi de cannabinoides: m\u00e8tode LC-MS\/MS validat per a 6 an\u00e0lits\" \/>\n<meta property=\"og:description\" content=\"Sis cannabinoides, un sol m\u00e8tode: an\u00e0lisi LC-MS\/MS validada amb una gran sensibilitat i selectivitat a Kymos Group.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/kymos.com\/ca\/news\/solucions-integrals-per-a-estudis-preclinics-de-salut-animal-de-bioequivalencia-i-clinics\/\" \/>\n<meta property=\"og:site_name\" content=\"Kymos\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-27T11:49:51+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-27T11:55:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/kymos.com\/wp-content\/uploads\/2026\/04\/Cannabinoid-Bioanalysis-6Analyte-Method-Header.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1600\" \/>\n\t<meta property=\"og:image:height\" content=\"900\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Sandra Magdaleno\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@KymosGroup\" \/>\n<meta name=\"twitter:site\" content=\"@KymosGroup\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"Sandra Magdaleno\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/kymos.com\\\/ca\\\/news\\\/solucions-integrals-per-a-estudis-preclinics-de-salut-animal-de-bioequivalencia-i-clinics\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/ca\\\/news\\\/solucions-integrals-per-a-estudis-preclinics-de-salut-animal-de-bioequivalencia-i-clinics\\\/\"},\"author\":{\"name\":\"Sandra Magdaleno\",\"@id\":\"https:\\\/\\\/kymos.com\\\/ca\\\/#\\\/schema\\\/person\\\/b0ed444c71c4c8afa6f4ae674967c999\"},\"headline\":\"Bioan\u00e0lisi de cannabinoides: un m\u00e8tode LC-MS\\\/MS multian\u00e0lit validat en plasma hum\u00e0\",\"datePublished\":\"2026-04-27T11:49:51+00:00\",\"dateModified\":\"2026-04-27T11:55:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/ca\\\/news\\\/solucions-integrals-per-a-estudis-preclinics-de-salut-animal-de-bioequivalencia-i-clinics\\\/\"},\"wordCount\":1261,\"image\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/ca\\\/news\\\/solucions-integrals-per-a-estudis-preclinics-de-salut-animal-de-bioequivalencia-i-clinics\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/kymos.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/Cannabinoid-Bioanalysis-6Analyte-Method-Header.png\",\"articleSection\":[\"Bioan\u00e0lisi\",\"General\"],\"inLanguage\":\"ca\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/kymos.com\\\/ca\\\/news\\\/solucions-integrals-per-a-estudis-preclinics-de-salut-animal-de-bioequivalencia-i-clinics\\\/\",\"url\":\"https:\\\/\\\/kymos.com\\\/ca\\\/news\\\/solucions-integrals-per-a-estudis-preclinics-de-salut-animal-de-bioequivalencia-i-clinics\\\/\",\"name\":\"Bioan\u00e0lisi de cannabinoides: m\u00e8tode LC-MS\\\/MS validat per a 6 an\u00e0lits\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/ca\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/ca\\\/news\\\/solucions-integrals-per-a-estudis-preclinics-de-salut-animal-de-bioequivalencia-i-clinics\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/ca\\\/news\\\/solucions-integrals-per-a-estudis-preclinics-de-salut-animal-de-bioequivalencia-i-clinics\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/kymos.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/Cannabinoid-Bioanalysis-6Analyte-Method-Header.png\",\"datePublished\":\"2026-04-27T11:49:51+00:00\",\"dateModified\":\"2026-04-27T11:55:39+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/ca\\\/#\\\/schema\\\/person\\\/b0ed444c71c4c8afa6f4ae674967c999\"},\"description\":\"Sis cannabinoides, un sol m\u00e8tode: an\u00e0lisi LC-MS\\\/MS validada amb una gran sensibilitat i selectivitat a Kymos Group.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/ca\\\/news\\\/solucions-integrals-per-a-estudis-preclinics-de-salut-animal-de-bioequivalencia-i-clinics\\\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/kymos.com\\\/ca\\\/news\\\/solucions-integrals-per-a-estudis-preclinics-de-salut-animal-de-bioequivalencia-i-clinics\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\\\/\\\/kymos.com\\\/ca\\\/news\\\/solucions-integrals-per-a-estudis-preclinics-de-salut-animal-de-bioequivalencia-i-clinics\\\/#primaryimage\",\"url\":\"https:\\\/\\\/kymos.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/Cannabinoid-Bioanalysis-6Analyte-Method-Header.png\",\"contentUrl\":\"https:\\\/\\\/kymos.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/Cannabinoid-Bioanalysis-6Analyte-Method-Header.png\",\"width\":1600,\"height\":900},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/kymos.com\\\/ca\\\/news\\\/solucions-integrals-per-a-estudis-preclinics-de-salut-animal-de-bioequivalencia-i-clinics\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/kymos.com\\\/ca\\\/inici\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bioan\u00e0lisi de cannabinoides: un m\u00e8tode LC-MS\\\/MS multian\u00e0lit validat en plasma hum\u00e0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/kymos.com\\\/ca\\\/#website\",\"url\":\"https:\\\/\\\/kymos.com\\\/ca\\\/\",\"name\":\"Kymos Group\",\"description\":\"Kymos Group\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/kymos.com\\\/ca\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ca\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/kymos.com\\\/ca\\\/#\\\/schema\\\/person\\\/b0ed444c71c4c8afa6f4ae674967c999\",\"name\":\"Sandra Magdaleno\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/bc2f5bf2cac304990fdc84e9a3ed0b47c89ed981aaa966dfb2f3c3f39f531df6?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/bc2f5bf2cac304990fdc84e9a3ed0b47c89ed981aaa966dfb2f3c3f39f531df6?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/bc2f5bf2cac304990fdc84e9a3ed0b47c89ed981aaa966dfb2f3c3f39f531df6?s=96&d=mm&r=g\",\"caption\":\"Sandra Magdaleno\"},\"url\":\"https:\\\/\\\/kymos.com\\\/ca\\\/news\\\/author\\\/sandra-magdaleno\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bioan\u00e0lisi de cannabinoides: m\u00e8tode LC-MS\/MS validat per a 6 an\u00e0lits","description":"Sis cannabinoides, un sol m\u00e8tode: an\u00e0lisi LC-MS\/MS validada amb una gran sensibilitat i selectivitat a Kymos Group.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/kymos.com\/ca\/news\/solucions-integrals-per-a-estudis-preclinics-de-salut-animal-de-bioequivalencia-i-clinics\/","og_locale":"ca_ES","og_type":"article","og_title":"Bioan\u00e0lisi de cannabinoides: m\u00e8tode LC-MS\/MS validat per a 6 an\u00e0lits","og_description":"Sis cannabinoides, un sol m\u00e8tode: an\u00e0lisi LC-MS\/MS validada amb una gran sensibilitat i selectivitat a Kymos Group.","og_url":"https:\/\/kymos.com\/ca\/news\/solucions-integrals-per-a-estudis-preclinics-de-salut-animal-de-bioequivalencia-i-clinics\/","og_site_name":"Kymos","article_published_time":"2026-04-27T11:49:51+00:00","article_modified_time":"2026-04-27T11:55:39+00:00","og_image":[{"width":1600,"height":900,"url":"https:\/\/kymos.com\/wp-content\/uploads\/2026\/04\/Cannabinoid-Bioanalysis-6Analyte-Method-Header.png","type":"image\/png"}],"author":"Sandra Magdaleno","twitter_card":"summary_large_image","twitter_creator":"@KymosGroup","twitter_site":"@KymosGroup","twitter_misc":{"Escrit per":"Sandra Magdaleno","Temps estimat de lectura":"6 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/kymos.com\/ca\/news\/solucions-integrals-per-a-estudis-preclinics-de-salut-animal-de-bioequivalencia-i-clinics\/#article","isPartOf":{"@id":"https:\/\/kymos.com\/ca\/news\/solucions-integrals-per-a-estudis-preclinics-de-salut-animal-de-bioequivalencia-i-clinics\/"},"author":{"name":"Sandra Magdaleno","@id":"https:\/\/kymos.com\/ca\/#\/schema\/person\/b0ed444c71c4c8afa6f4ae674967c999"},"headline":"Bioan\u00e0lisi de cannabinoides: un m\u00e8tode LC-MS\/MS multian\u00e0lit validat en plasma hum\u00e0","datePublished":"2026-04-27T11:49:51+00:00","dateModified":"2026-04-27T11:55:39+00:00","mainEntityOfPage":{"@id":"https:\/\/kymos.com\/ca\/news\/solucions-integrals-per-a-estudis-preclinics-de-salut-animal-de-bioequivalencia-i-clinics\/"},"wordCount":1261,"image":{"@id":"https:\/\/kymos.com\/ca\/news\/solucions-integrals-per-a-estudis-preclinics-de-salut-animal-de-bioequivalencia-i-clinics\/#primaryimage"},"thumbnailUrl":"https:\/\/kymos.com\/wp-content\/uploads\/2026\/04\/Cannabinoid-Bioanalysis-6Analyte-Method-Header.png","articleSection":["Bioan\u00e0lisi","General"],"inLanguage":"ca"},{"@type":"WebPage","@id":"https:\/\/kymos.com\/ca\/news\/solucions-integrals-per-a-estudis-preclinics-de-salut-animal-de-bioequivalencia-i-clinics\/","url":"https:\/\/kymos.com\/ca\/news\/solucions-integrals-per-a-estudis-preclinics-de-salut-animal-de-bioequivalencia-i-clinics\/","name":"Bioan\u00e0lisi de cannabinoides: m\u00e8tode LC-MS\/MS validat per a 6 an\u00e0lits","isPartOf":{"@id":"https:\/\/kymos.com\/ca\/#website"},"primaryImageOfPage":{"@id":"https:\/\/kymos.com\/ca\/news\/solucions-integrals-per-a-estudis-preclinics-de-salut-animal-de-bioequivalencia-i-clinics\/#primaryimage"},"image":{"@id":"https:\/\/kymos.com\/ca\/news\/solucions-integrals-per-a-estudis-preclinics-de-salut-animal-de-bioequivalencia-i-clinics\/#primaryimage"},"thumbnailUrl":"https:\/\/kymos.com\/wp-content\/uploads\/2026\/04\/Cannabinoid-Bioanalysis-6Analyte-Method-Header.png","datePublished":"2026-04-27T11:49:51+00:00","dateModified":"2026-04-27T11:55:39+00:00","author":{"@id":"https:\/\/kymos.com\/ca\/#\/schema\/person\/b0ed444c71c4c8afa6f4ae674967c999"},"description":"Sis cannabinoides, un sol m\u00e8tode: an\u00e0lisi LC-MS\/MS validada amb una gran sensibilitat i selectivitat a Kymos Group.","breadcrumb":{"@id":"https:\/\/kymos.com\/ca\/news\/solucions-integrals-per-a-estudis-preclinics-de-salut-animal-de-bioequivalencia-i-clinics\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/kymos.com\/ca\/news\/solucions-integrals-per-a-estudis-preclinics-de-salut-animal-de-bioequivalencia-i-clinics\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/kymos.com\/ca\/news\/solucions-integrals-per-a-estudis-preclinics-de-salut-animal-de-bioequivalencia-i-clinics\/#primaryimage","url":"https:\/\/kymos.com\/wp-content\/uploads\/2026\/04\/Cannabinoid-Bioanalysis-6Analyte-Method-Header.png","contentUrl":"https:\/\/kymos.com\/wp-content\/uploads\/2026\/04\/Cannabinoid-Bioanalysis-6Analyte-Method-Header.png","width":1600,"height":900},{"@type":"BreadcrumbList","@id":"https:\/\/kymos.com\/ca\/news\/solucions-integrals-per-a-estudis-preclinics-de-salut-animal-de-bioequivalencia-i-clinics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/kymos.com\/ca\/inici\/"},{"@type":"ListItem","position":2,"name":"Bioan\u00e0lisi de cannabinoides: un m\u00e8tode LC-MS\/MS multian\u00e0lit validat en plasma hum\u00e0"}]},{"@type":"WebSite","@id":"https:\/\/kymos.com\/ca\/#website","url":"https:\/\/kymos.com\/ca\/","name":"Kymos Group","description":"Kymos Group","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/kymos.com\/ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ca"},{"@type":"Person","@id":"https:\/\/kymos.com\/ca\/#\/schema\/person\/b0ed444c71c4c8afa6f4ae674967c999","name":"Sandra Magdaleno","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/secure.gravatar.com\/avatar\/bc2f5bf2cac304990fdc84e9a3ed0b47c89ed981aaa966dfb2f3c3f39f531df6?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/bc2f5bf2cac304990fdc84e9a3ed0b47c89ed981aaa966dfb2f3c3f39f531df6?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bc2f5bf2cac304990fdc84e9a3ed0b47c89ed981aaa966dfb2f3c3f39f531df6?s=96&d=mm&r=g","caption":"Sandra Magdaleno"},"url":"https:\/\/kymos.com\/ca\/news\/author\/sandra-magdaleno\/"}]}},"_links":{"self":[{"href":"https:\/\/kymos.com\/ca\/wp-json\/wp\/v2\/posts\/37998","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kymos.com\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kymos.com\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kymos.com\/ca\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/kymos.com\/ca\/wp-json\/wp\/v2\/comments?post=37998"}],"version-history":[{"count":4,"href":"https:\/\/kymos.com\/ca\/wp-json\/wp\/v2\/posts\/37998\/revisions"}],"predecessor-version":[{"id":38089,"href":"https:\/\/kymos.com\/ca\/wp-json\/wp\/v2\/posts\/37998\/revisions\/38089"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/kymos.com\/ca\/wp-json\/wp\/v2\/media\/38005"}],"wp:attachment":[{"href":"https:\/\/kymos.com\/ca\/wp-json\/wp\/v2\/media?parent=37998"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kymos.com\/ca\/wp-json\/wp\/v2\/categories?post=37998"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kymos.com\/ca\/wp-json\/wp\/v2\/tags?post=37998"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}